Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 18 studies | 31% ± 12% | |
lung | 15 studies | 24% ± 8% | |
brain | 7 studies | 31% ± 9% | |
kidney | 5 studies | 28% ± 5% | |
lymph node | 5 studies | 26% ± 13% | |
intestine | 5 studies | 21% ± 6% | |
liver | 5 studies | 28% ± 5% | |
pancreas | 4 studies | 47% ± 26% | |
bone marrow | 4 studies | 24% ± 9% | |
uterus | 4 studies | 29% ± 15% | |
placenta | 3 studies | 20% ± 3% | |
eye | 3 studies | 17% ± 1% | |
breast | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 12346.26 | 1445 / 1445 | 100% | 148.77 | 183 / 183 |
intestine | 100% | 17930.77 | 966 / 966 | 100% | 169.83 | 527 / 527 |
lung | 100% | 18653.98 | 578 / 578 | 100% | 137.28 | 1152 / 1155 |
stomach | 100% | 11874.63 | 359 / 359 | 100% | 172.64 | 285 / 286 |
ovary | 100% | 12827.15 | 180 / 180 | 100% | 97.92 | 428 / 430 |
breast | 100% | 15417.07 | 459 / 459 | 99% | 170.46 | 1111 / 1118 |
prostate | 100% | 13460.62 | 245 / 245 | 99% | 143.21 | 498 / 502 |
thymus | 100% | 18045.70 | 653 / 653 | 99% | 171.05 | 598 / 605 |
brain | 99% | 10483.51 | 2625 / 2642 | 99% | 109.26 | 701 / 705 |
kidney | 100% | 17703.88 | 89 / 89 | 98% | 202.06 | 886 / 901 |
pancreas | 99% | 7418.32 | 324 / 328 | 99% | 158.04 | 177 / 178 |
skin | 100% | 13997.74 | 1809 / 1809 | 98% | 150.14 | 462 / 472 |
bladder | 100% | 15202.67 | 21 / 21 | 98% | 116.16 | 492 / 504 |
liver | 100% | 12020.18 | 226 / 226 | 98% | 122.39 | 396 / 406 |
uterus | 100% | 15727.75 | 170 / 170 | 97% | 91.39 | 444 / 459 |
adrenal gland | 100% | 15526.60 | 258 / 258 | 93% | 120.62 | 214 / 230 |
adipose | 100% | 16062.96 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 21722.57 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 97.74 | 29 / 29 |
spleen | 100% | 16946.48 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 37.21 | 1 / 1 |
heart | 99% | 9411.74 | 850 / 861 | 0% | 0 | 0 / 0 |
muscle | 99% | 6157.69 | 792 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 14876.73 | 915 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 87.08 | 44 / 45 |
eye | 0% | 0 | 0 / 0 | 96% | 84.18 | 77 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005768 | Cellular component | endosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0030669 | Cellular component | clathrin-coated endocytic vesicle membrane |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005886 | Cellular component | plasma membrane |
GO_0030140 | Cellular component | trans-Golgi network transport vesicle |
GO_0030133 | Cellular component | transport vesicle |
GO_0005515 | Molecular function | protein binding |
Gene name | TGOLN2 |
Protein name | Trans-golgi network protein 2 Trans-Golgi network integral membrane protein 2 (Trans-Golgi network glycoprotein 46) (TGN38 homolog) (hTGN46) (Trans-Golgi network glycoprotein 48) (hTGN48) (Trans-Golgi network glycoprotein 51) (hTGN51) (Trans-Golgi network protein 2) |
Synonyms | TGN46 TGN51 |
Description | FUNCTION: May be involved in regulating membrane traffic to and from trans-Golgi network. |
Accessions | ENST00000710332.1 [O43493-4] ENST00000409015.5 [O43493-7] O43493 A0A5F9UY30 ENST00000409232.7 ENST00000377386.8 [O43493-2] ENST00000444342.2 [O43493-5] ENST00000398263.6 [O43493-4] |